These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7001226)

  • 1. Mutagenicity of extracts of urine from rats treated with aromatic amines.
    Tanaka KI; Marui S; Mii T
    Mutat Res; 1980 Oct; 79(2):173-6. PubMed ID: 7001226
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenicity studies with o-tolidine and 4,4'-tetramethyldiaminodiphenylmethane.
    Waalkens DH; Joosten HF; Yih TD; Hoekstra A
    Mutat Res; 1981 Jul; 89(3):197-202. PubMed ID: 7022193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of urine mutagenicity to monitor coal liquefaction workers.
    Recio L; Enoch HG; Hannan MA; Hill RH
    Mutat Res; 1984 Jun; 136(3):201-7. PubMed ID: 6377056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure.
    Doolittle DJ; Lee DA; Rahn CA
    Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of non-oxidative enzymes in mutagenic activation of urine from rats, given benzidine and some other aromatic amines.
    Bos RP; Brouns RM; van Doorn R; Theuws JL; Henderson PT
    Toxicology; 1981; 21(3):223-33. PubMed ID: 7027539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unambiguous synthesis of asymmetrically substituted chlorinated benzidines, and a study of their mutagenicity in the Ames test: potent activity of 3,5,3'-trichlorobenzidine.
    Josephy PD; Williams LL
    Mutagenesis; 1987 May; 2(3):225-8. PubMed ID: 3325748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of some benzidine analogues for microsomal activation to bacterial mutagens.
    Garner RC
    Cancer Lett; 1975 Sep; 1(1):39-42. PubMed ID: 797441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
    Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quantitative structure-activity relationship approach to the mutagenicity of N-nitrosomethylaniline compounds.
    Jinno K
    Mutat Res; 1984; 141(3-4):141-3. PubMed ID: 6392878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of some congeners of benzidine in the Salmonella typhimurium assay system.
    Lazear EJ; Louie SC
    Cancer Lett; 1978 Jan; 4(1):21-5. PubMed ID: 342090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of the mutagenic and carcinogenic activity of various aromatic amines].
    Pogodina ON; Svetlova MP; Tomilin NV; Pliss GB; Khudoleĭ VV
    Eksp Onkol; 1984; 6(4):23-5. PubMed ID: 6389088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test].
    Khudoleĭ VV; Bartsch H; Malaveille C
    Vopr Onkol; 1981; 27(12):47-51. PubMed ID: 7034364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.
    Miyanishi K; Kinouchi T; Kataoka K; Kanoh T; Ohnishi Y
    Carcinogenesis; 1996 Jul; 17(7):1483-90. PubMed ID: 8706253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutagenicity of 2-nitrofluoranthene and its in vitro hepatic metabolites.
    Zielinska B; Harger WP; Arey J; Winer AM; Haas RA; Hanson CV
    Mutat Res; 1987 Apr; 190(4):259-66. PubMed ID: 3550452
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic aspects of the comutagenic action of norharman.
    Sugimura T; Nagao M; Wakabayashi K
    Adv Exp Med Biol; 1981; 136 Pt B():1011-25. PubMed ID: 7046384
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates, with particular relevance to assays carried out using the bacterial fluctuation test.
    Gibson JF; Baxter PJ; Hedworth-Whitty RB; Gompertz D
    Carcinogenesis; 1983 Nov; 4(11):1471-6. PubMed ID: 6357523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.